Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Forkhead box P3 (FOXP3) is currently thought to be the most specific marker for naturally occurring CD4(+)CD25(+) T regulatory cells (nTregs). In mice, expression of FoxP3 is strictly correlated with regulatory activity, whereas increasing evidence suggests that in humans, activated T effector cells (Teffs) may also express FOXP3. In order to better define the role of FOXP3 in human Teff cells, we investigated the intensity and kinetics of expression in ex vivo Teff cells, suppressed Teff cells and Teff cell lines. We found that all dividing Teff cells expressed FOXP3, but only transiently, and at levels that were significantly lower than those in suppressive nTregs. This temporary expression in Teff cells was insufficient to suppress expression of reported targets of FOXP3 repressor activity, including CD127, IL-2 and IFN-gamma, and was not correlated with induction of a nTreg phenotype. Thus expression of FOXP3 is a normal consequence of CD4(+) T cell activation and, in humans, it can no longer be used as an exclusive marker of nTregs. These data indicate that our current understanding of how FOXP3 contributes to immune tolerance in humans needs to be re-evaluated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Moreover, even within Tregs the intensity of FOXP3 expression can change, with naive or resting populations of Tregs expressing lower levels of FOXP3 than activated Tregs [379, 380].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [380]
The cited source says what the claim attributes to it.
In the citing paper
“Since Tconvs can also upregulate CD25 and FOXP3, and downregulate CD127 [380, 386], it is critical to set gates for all of these markers on resting populations of T cells, typically using blood cells from healthy individuals.”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [380]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Chen, W., Jin, W., Hardegen, N., Lei, K.-J., Li, L., Marinos, N., McGrady, G., & Wahl, S. M. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030152 · Cited by 4,699
An essential role for Scurfin in CD4+CD25+ T regulatory cells
Khattri, R., Cox, T., Yasayko, S.-A., & Ramsdell, F. (2003) · Nature Immunology · doi:10.1038/ni909 · Cited by 2,856
CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells
Liu, W., Putnam, A. L., Xu-yu, Z., Szot, G. L., Lee, M. R., Zhu, S., Gottlieb, P. A., Kapranov, P., Gingeras, T. R., de St. Groth, B. F., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060772 · Cited by 2,606 · cited 2×
“Recently, it was reported that human nTregs can be distinguished from Teff cells on the basis of low CD127 (IL-7Ra) expression ( 26 , 27), possibly due to the capacity of FOXP3 to interact with and repress the CD127 promoter (26).”
BackgroundRegulatory T Cell Lineage Specification by the Forkhead Transcription Factor Foxp3
Fontenot, J. D., Rasmussen, J. P., Williams, L. M., Dooley, J. L., Farr, A. G., & Rudensky, A. Y. (2005) · Immunity · doi:10.1016/j.immuni.2005.01.016 · Cited by 2,279
Seddiki, N., Santner-Nanan, B., Martinson, J., Zaunders, J., Sasson, S., Landay, A., Solomon, M., Selby, W., Alexander, S. I., Nanan, R., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060468 · Cited by 1,512 · cited 1×
“Recently, it was reported that human nTregs can be distinguished from Teff cells on the basis of low CD127 (IL-7Ra) expression (26, 27 ), possibly due to the capacity of FOXP3 to interact with and repress the CD127 promoter (26).”
BackgroundTNF/TNFR FAMILY MEMBERS IN COSTIMULATION OF T CELL RESPONSES
Watts, T. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115839 · Cited by 1,353
Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25– T cells
R.Walker, M., Kasprowicz, D. J., Gersuk, V. H., Bènard, A., Van Landeghen, M., Buckner, J. H., & Ziegler, S. F. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19441 · Cited by 1,245
FOXP3 Controls Regulatory T Cell Function through Cooperation with NFAT
Wu, Y., Borde, M., Heissmeyer, V., Feuerer, M., Lapan, A. D., Stroud, J. C., Bates, D. L., Guo, L., Han, A., Ziegler, S. F., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.042 · Cited by 1,189
Cited by
Vignali, D. A. A., Collison, L. W., & Workman, C. J. (2008) · Nature Reviews Immunology · doi:10.1038/nri2343 · Cited by 3,463
FOXP3+ regulatory T cells in the human immune system
Sakaguchi, S., Miyara, M., Costantino, C. M., & Hafler, D. A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2785 · Cited by 2,439
“Only ∼1–2% of cells with the highest CD25 expression have been shown to be functionally suppressive and can be considered T Reg cell”
BackgroundMiyara, M., Yoshioka, Y., Kitoh, A., Shima, T., Wing, K., Niwa, A., Parizot, C., Taflin, C., Heike, T., Valeyre, D., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.03.019 · Cited by 2,291
“For example, it has been reported that mere TCR stimulation can induce FoxP3 expression in apparently naive human FoxP3 CD4 T cells without conferring suppressive activity (Allan et al., 2007; Gavin et al., 2006; Tran et al., 2007; Wang et al., 2007).”
BackgroundInfluentialThornton, A. M., Korty, P. E., Tran, D. Q., Wohlfert, E. A., Murray, P. E., Belkaid, Y., & Shevach, E. M. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904028 · Cited by 1,382
“Although human CD4Foxp3(2) T cells can be induced to express Foxp3 by stimulation in vitro in the presence of TGF-b, they lack regulatory function (26, 27).”
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
Cossarizza, A., Chang, H., Radbruch, A., Acs, A., Adam, D., Adam‐Klages, S., Agace, W. W., Aghaeepour, N., Akdis, M., Allez, M., et al. (2019) · European Journal of Immunology · doi:10.1002/eji.201970107 · Cited by 979
Jeffery, L. E., Burke, F., Mura, M., Zheng, Y., Qureshi, O. S., Hewison, M., Walker, L. S. K., Lammas, D. A., Raza, K., & Sansom, D. M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803217 · Cited by 789
“Because the expression of FoxP3 in induced Tregs is thought to be transient (39, 40), we analyzed the kinetics of the response to determine whether 1,25(OH)2D3 treatment was able to sustain the expression of CTLA-4 and FoxP3.”
BackgroundDNA methylation controls Foxp3 gene expression
Polansky, J. K., Kretschmer, K., Freyer, J., Floess, S., Garbe, A., Baron, U., Olek, S., Hamann, A., von Boehmer, H., & Huehn, J. (2008) · European Journal of Immunology · doi:10.1002/eji.200838105 · Cited by 785
Molecular Mechanisms of Treg-Mediated T Cell Suppression
Schmidt, A., Oberle, N., & Krammer, P. H. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00051 · Cited by 761
Ohkura, N., Hamaguchi, M., Morikawa, H., Sugimura, K., Tanaka, A., Ito, Y., Osaki, M., Tanaka, Y., Yamashita, R., Nakano, N., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.09.010 · Cited by 754
“Moreover, T cell receptor (TCR) stimulation can induce transient Foxp3 expression in naive T cells, but not suppressive activity, in humans (Allan et al., 2007; Miyara et al., 2009).”
BackgroundTran, D. Q., Ramsey, H., & Shevach, E. M. (2007) · Blood · doi:10.1182/blood-2007-06-094656 · Cited by 743
Development and Maintenance of Regulatory T cells
Ohkura, N., Kitagawa, Y., & Sakaguchi, S. (2013) · Immunity · doi:10.1016/j.immuni.2013.03.002 · Cited by 728
“For example, activated human Tconv cells transiently express FOXP3 at a low level without acquiring Treg cell suppressive activity (Allan et al., 2007).”
BackgroundAnalysis of islet inflammation in human type 1 diabetes
Willcox, A., Richardson, S. J., Bone, A. J., Foulis, A. K., & Morgan, N. G. (2009) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2008.03860.x · Cited by 712
Baron, U., Floess, S., Wieczorek, G., Baumann, K., Grützkau, A., Dong, J., Thiel, A., Boeld, T. J., Hoffmann, P., Edinger, M., et al. (2007) · European Journal of Immunology · doi:10.1002/eji.200737594 · Cited by 694
How do Regulatory T Cells Work?
Corthay, A. (2009) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2009.02308.x · Cited by 648
Hill, J. A., Feuerer, M., Tash, K., Haxhinasto, S., Perez, J., Melamed, R., Mathis, D., & Benoist, C. (2007) · Immunity · doi:10.1016/j.immuni.2007.09.010 · Cited by 632
“…are not met by Foxp3: Whether after induction by TGF-b or after retroviral transduction, Foxp3 is not sufficient to elicit the full Treg cell signature (similarly, activated human Tconv cells express some Foxp3, yet show no suppressive characteristics [Walker et al., 2003; Allan et al., 2007]).”
BackgroundMiyao, T., Floess, S., Setoguchi, R., Luche, H., Fehling, H. J., Waldmann, H., Huehn, J., & Hori, S. (2012) · Immunity · doi:10.1016/j.immuni.2011.12.012 · Cited by 610
“However, Foxp3 expression may not always specify Treg cells; in humans, activated T cells transiently upregulate FOXP3 without acquiring a Treg cell phenotype and function (Allan et al., 2007; Gavin et al., 2006; Tran et al., 2007; Wang et al., 2007; Ziegler, 2006), although such ‘‘promiscuous’’ Foxp3 expression has n…”
BackgroundEpigenetic Regulation of Foxp3 Expression in Regulatory T Cells by DNA Methylation
Lal, G., Zhang, N., van der Touw, W., Ding, Y., Ju, W., Bottinger, E. P., Reid, S. P., Levy, D. E., & Bromberg, J. S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.259 · Cited by 559
“Foxp3 expression in human CD4 T cells does not necessarily denote a regulatory phenotype (44, 54).”
BackgroundHamid, O., Schmidt, H., Nissan, A., Ridolfi, L., Aamdal, S., Hansson, J., Guida, M., Hyams, D. M., Gómez, H., Bastholt, L., et al. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-204 · Cited by 534
“Thus, intratumoral expression of IDO may have promoted the accumulation of FoxP3 cells; however, recent findings suggest that FoxP3 may not be specific for Tregs, but can also be expressed by other activated T-cell populations [66].”
ResultEpigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage?
Huehn, J., Polansky, J. K., & Hamann, A. (2009) · Nature Reviews Immunology · doi:10.1038/nri2474 · Cited by 526
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
Cossarizza, A., Chang, H., Radbruch, A., Abrignani, S., Addo, R., Akdis, M., Andrä, I., Andreata, F., Annunziato, F., Arranz, E., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202170126 · Cited by 531
Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment?
Guerin, L. R., Prins, J. R., & Robertson, S. A. (2009) · Human Reproduction Update · doi:10.1093/humupd/dmp004 · Cited by 498
“This has led to speculation that FOXP3 induction and subsequent suppression might be a default pathway in the activation of all human T-cells (Pillai and Karandikar, 2007); however, debate continues over the suppressive qualities of transiently FOXP3þ T-cells (Allan et al., 2007).”
BackgroundTargeting Treg cells in cancer immunotherapy
Tanaka, A., & Sakaguchi, S. (2019) · European Journal of Immunology · doi:10.1002/eji.201847659 · Cited by 476
Gandhi, R., Kumar, D., Burns, E. J., Nadeau, M., Dake, B., Laroni, A., Kozoriz, D., Weiner, H. L., & Quintana, F. J. (2010) · Nature Immunology · doi:10.1038/ni.1915 · Cited by 476
“In humans, however, Foxp3 expression is not always linked to regulatory function: activated T cells transiently express Foxp3 (refs”
BackgroundMieli-Vergani, G., Vergani, D., Czaja, A. J., Manns, M. P., Krawitt, E. L., Vierling, J. M., Lohse, A. W., & Montano-Loza, A. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.17 · Cited by 425
Milne, K., Köbel, M., Kalloger, S. E., Barnes, R. O., Gao, D., Gilks, C. B., Watson, P. H., & Nelson, B. H. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006412 · Cited by 446
“Although FoxP3 is still regarded as the most reliable marker of Tregs in human cancer [82,83], it can also be expressed by epithelial tumor cells [84-86] and in vitro activated CD4+ and CD8+ T cells [87-95].”
BackgroundPlasticity of Human Regulatory T Cells in Healthy Subjects and Patients with Type 1 Diabetes
McClymont, S. A., Putnam, A. L., Lee, M. R., Esensten, J. H., Liu, W., Hulme, M. A., Hoffmüller, U., Baron, U., Olek, S., Bluestone, J. A., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003099 · Cited by 428
Leffers, N., Gooden, M. J. M., de Jong, R. A., Hoogeboom, B.-N., ten Hoor, K. A., Hollema, H., Boezen, H. M., van der Zee, A. G. J., Daemen, T., & Nijman, H. W. (2009) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-008-0583-5 · Cited by 402
“Recently, it was shown that activated CD4+CD25¡ eVector T cells transiently express FoxP3, without having regulatory activity [2, 23].”
BackgroundEastaff-Leung, N., Mabarrack, N., Barbour, A., Cummins, A., & Barry, S. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-009-9345-1 · Cited by 392
“CD25 is not an exclusive marker for Treg [ 4 ].”
BackgroundInfluentialMizukami, Y., Kono, K., Kawaguchi, Y., Akaike, H., Kamimura, K., Sugai, H., & Fujii, H. (2008) · International Journal of Cancer · doi:10.1002/ijc.23392 · Cited by 374
Control of Foxp3 stability through modulation of TET activity
Yue, X., Trifari, S., Äijö, T., Tsagaratou, A., Pastor, W. A., Zepeda-Martínez, J. A., Lio, C.-W. J., Li, X., Huang, Y., Vijayanand, P., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151438 · Cited by 355
“To initiate iT reg cell differentiation, naive T cells from Foxp3-IRE S-eGFP reporter mice were treated with TGF -β alone (Chen et al., 2003) or with TGF -β + RA (Benson et al., 2007) in the presence or absence of vitamin C.”
BackgroundMethodMemory regulatory T cells reside in human skin
Sanchez Rodriguez, R., Pauli, M. L., Neuhaus, I. M., Yu, S. S., Arron, S. T., Harris, H. W., Yang, S. H.-Y., Anthony, B. A., Sverdrup, F. M., Krow-Lucal, E., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72932 · Cited by 354
“In addition, Foxp3-expressing Tconvs express lower levels of CD25 and do not repress CD127 expression or IL-2 production (23).”
Ohkura, N., & Sakaguchi, S. (2020) · Cell Research · doi:10.1038/s41422-020-0324-7 · Cited by 353
Bao, W., Bussel, J. B., Heck, S., He, W., Karpoff, M., Boulad, N., & Yazdanbakhsh, K. (2010) · Blood · doi:10.1182/blood-2010-04-281717 · Cited by 345
The development and function of regulatory T cells
Workman, C. J., Szymczak-Workman, A. L., Collison, L. W., Pillai, M. R., & Vignali, D. A. A. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0026-2 · Cited by 344
Human FoxP3+ regulatory T cells in systemic autoimmune diseases
Miyara, M., Gorochov, G., Ehrenstein, M., Musset, L., Sakaguchi, S., & Amoura, Z. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.05.004 · Cited by 342
CD4+FoxP3+ regulatory T cells confer infectious tolerance in a TGF-β–dependent manner
Andersson, J., Tran, D. Q., Pesu, M., Davidson, T. S., Ramsey, H., O'Shea, J. J., & Shevach, E. M. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080308 · Cited by 337
From IPEX syndrome to FOXP3 mutation: a lesson on immune dysregulation
Bacchetta, R., Barzaghi, F., & Roncarolo, M. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13011 · Cited by 338
Self-citationBarzaghi, F., Passerini, L., & Bacchetta, R. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00211 · Cited by 325
“In humans, FOXP3 is also expressed transiently upon activation, in conventional Teff cells (Allan et al., 2007; Tran et al., 2007; Passerini et al., 2008), in which a still unknown function has been postulated (Ziegler, 2006; McMurchy et al., 2010).”
BackgroundSelf-citationMechanism of cellular rejection in transplantation
Ingulli, E. (2010) · Pediatric Nephrology · doi:10.1007/s00467-008-1020-x · Cited by 313
Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis
Flores-Borja, F., Jury, E. C., Mauri, C., & Ehrenstein, M. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806855105 · Cited by 312
Strainic, M. G., Shevach, E. M., An, F., Lin, F., & Medof, M. E. (2013) · Nature Immunology · doi:10.1038/ni.2499 · Cited by 302
Regulatory T cells in the treatment of disease
Sharabi, A., Tsokos, M. G., Ding, Y., Malek, T. R., Klatzmann, D., & Tsokos, G. C. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.148 · Cited by 297
Regulatory T-cells in autoimmune diseases: Challenges, controversies and—yet—unanswered questions
Grant, C. R., Liberal, R., Mieli-Vergani, G., Vergani, D., & Longhi, M. S. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2014.10.012 · Cited by 292
“fact, the majority of the defining markers – CD25 [39], FOXP3 [90, 91] and CTLA-4 [92] for”
BackgroundTakahashi, R., Kano, Y., Yamazaki, Y., Kimishima, M., Mizukawa, Y., & Shiohara, T. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804002 · Cited by 276
“Nevertheless, it was also possible that the increased frequency of Treg cells observed in DIHS merely reflects the overall status of activation of T cells, because recent studies on human Treg cells have demonstrated that TCR stimulation alone with anti-CD3 and anti-CD28 induces Foxp3 expression without acquisition of…”
BackgroundPeripherally Induced Tregs – Role in Immune Homeostasis and Autoimmunity
Yadav, M., Stephan, S., & Bluestone, J. A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00232 · Cited by 273
Torgerson, T. R., & Ochs, H. D. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.08.044 · Cited by 272
West, N. R., Kost, S. E., Martin, S. D., Milne, K., deLeeuw, R. J., Nelson, B. H., & Watson, P. H. (2013) · British Journal of Cancer · doi:10.1038/bjc.2012.524 · Cited by 268
Kavanagh, B., O'Brien, S., Lee, D., Hou, Y., Weinberg, V., Rini, B., Allison, J. P., Small, E. J., & Fong, L. (2008) · Blood · doi:10.1182/blood-2007-11-125435 · Cited by 256
Beers, D. R., Zhao, W., Wang, J., Zhang, X., Wen, S., Neal, D., Thonhoff, J. R., Alsuliman, A. S., Shpall, E. J., Rezvani, K., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.89530 · Cited by 254
“Although studies in mice have shown FoxP3 to be a direct marker of Tregs, FOXP3 has also been shown to be transiently upregulated upon activation of human Tresps (41, 42).”
BackgroundEvans, H. G., Suddason, T., Jackson, I., Taams, L. S., & Lord, G. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708426104 · Cited by 255
Telesford, K. M., Yan, W., Ochoa-Reparaz, J., Pant, A., Kircher, C., Christy, M. A., Begum-Haque, S., Kasper, D. L., & Kasper, L. H. (2015) · Gut Microbes · doi:10.1080/19490976.2015.1056973 · Cited by 252
Role of regulatory T cells and FOXP3 in human diseases
Bacchetta, R., Gambineri, E., & Roncarolo, M.-G. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.06.023 · Cited by 249
Self-citationA role for the transcription factor Helios in human CD4+CD25+ regulatory T cells
Getnet, D., Grosso, J. F., Goldberg, M. V., Harris, T. J., Yen, H.-R., Bruno, T. C., Durham, N. M., Hipkiss, E. L., Pyle, K. J., & Wada, S. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.02.001 · Cited by 248
Sawant, D. V., & Vignali, D. A. A. (2014) · Immunological Reviews · doi:10.1111/imr.12173 · Cited by 245
Function and Role of Regulatory T Cells in Rheumatoid Arthritis
Jiang, Q., Yang, G., Liu, Q., Wang, S., & Cui, D. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.626193 · Cited by 246
“Tconv cells also express a low level of Foxp3 upon TCR stimulation (75, 76).”
BackgroundTherapeutic targeting of regulatory T cells in cancer
Shan, F., Somasundaram, A., Bruno, T. C., Workman, C. J., & Vignali, D. A. A. (2022) · Trends in Cancer · doi:10.1016/j.trecan.2022.06.008 · Cited by 244
FOXP3 Promoter Demethylation Reveals the Committed Treg Population in Humans
Janson, P. C. J., Winerdal, M. E., Marits, P., Thörn, M., Ohlsson, R., & Winqvist, O. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001612 · Cited by 234
“Just as CD25, FOXP3 is transiently upregulated in human CD4CD25 T cells upon activation [10–15] and although this FOXP3 expression is associated with hyporesponsiveness and decreased cytokine production, results regarding the suppressive ability of these cells differ [14,16,17].”
BackgroundAllan, S. E., Alstad, A. N., Merindol, N., Crellin, N. K., Amendola, M., Bacchetta, R., Naldini, L., Roncarolo, M. G., Soudeyns, H., & Levings, M. K. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300341 · Cited by 233
Self-citationRegulatory T-Cell Therapy in Transplantation: Moving to the Clinic
Tang, Q., & Bluestone, J. A. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a015552 · Cited by 234
“Although CD3 and CD4 are clearly not unique for Tregs, conventional T cells transiently express FOXP3 after activation; therefore FOXP3 expression does not distinguish Tregs from conventional T cells either (Allan et al. 2007).”
BackgroundRegulatory T cells in autoimmune neuroinflammation
Kleinewietfeld, M., & Hafler, D. A. (2014) · Immunological Reviews · doi:10.1111/imr.12169 · Cited by 230
FOXP3 and scurfy: how it all began
Ramsdell, F., & Ziegler, S. F. (2014) · Nature Reviews Immunology · doi:10.1038/nri3650 · Cited by 226
Bour‐Jordan, H., & Bluestone, J. A. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00775.x · Cited by 223
CD4+ T‐regulatory cells: toward therapy for human diseases
Allan, S. E., Broady, R., Gregori, S., Himmel, M. E., Locke, N., Roncarolo, M. G., Bacchetta, R., & Levings, M. K. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00634.x · Cited by 223
Self-citationCirculating exosomes suppress the induction of regulatory T cells via let-7i in multiple sclerosis
Kimura, K., Hohjoh, H., Fukuoka, M., Sato, W., Oki, S., Tomi, C., Yamaguchi, H., Kondo, T., Takahashi, R., & Yamamura, T. (2018) · Nature Communications · doi:10.1038/s41467-017-02406-2 · Cited by 220
Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors
Zonios, D. I., Falloon, J., Bennett, J. E., Shaw, P. A., Chaitt, D., Baseler, M. W., Adelsberger, J. W., Metcalf, J. A., Polis, M. A., Kovacs, S. J., et al. (2008) · Blood · doi:10.1182/blood-2007-12-127878 · Cited by 217
Helios+ and Helios− Cells Coexist within the Natural FOXP3+ T Regulatory Cell Subset in Humans
Himmel, M. E., MacDonald, K. G., Garcia, R. V., Steiner, T. S., & Levings, M. K. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201379 · Cited by 217
“Similar to our previous finding with activationinduced expression of FOXP3 (27), expression of activation-induced Helios always remained significantly lower than in Helios nTreg”
ResultSelf-citationTREG-cell therapies for autoimmune rheumatic diseases
Miyara, M., Ito, Y., & Sakaguchi, S. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.105 · Cited by 214
Sumida, T. S., Cheru, N. T., & Hafler, D. A. (2024) · Nature Reviews Immunology · doi:10.1038/s41577-024-00994-x · Cited by 201
Passerini, L., Allan, S. E., Battaglia, M., Di Nunzio, S., Alstad, A. N., Levings, M. K., Roncarolo, M. G., & Bacchetta, R. (2008) · International Immunology · doi:10.1093/intimm/dxn002 · Cited by 200
Self-citationChowdary Venigalla, R. K., Tretter, T., Krienke, S., Max, R., Eckstein, V., Blank, N., Fiehn, C., Dick Ho, A., & Lorenz, H. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23556 · Cited by 196
Bonelli, M., Savitskaya, A., Steiner, C.-W., Rath, E., Smolen, J. S., & Scheinecker, C. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.3.1689 · Cited by 195
Terziroli Beretta-Piccoli, B., Mieli-Vergani, G., & Vergani, D. (2022) · Cellular & Molecular Immunology · doi:10.1038/s41423-021-00768-8 · Cited by 187
Zhu, Q., Egelston, C., Gagnon, S., Sui, Y., Belyakov, I. M., Klinman, D. M., & Berzofsky, J. A. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39293 · Cited by 186
The Regulatory T Cell–Associated Transcription Factor FoxP3 Is Expressed by Tumor Cells
Ebert, L. M., Tan, B. S., Browning, J., Svobodova, S., Russell, S. E., Kirkpatrick, N., Gedye, C., Moss, D., Ng, S. P., MacGregor, D., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5664 · Cited by 183
Regulatory T Cells as Immunotherapy
Singer, B. D., King, L. S., & D’Alessio, F. R. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00046 · Cited by 183
“Although Foxp3 expression specifies the Treg lineage in mice (31), T cells promiscuously express FOXP3 in humans (32).”
BackgroundGDF15 induces immunosuppression via CD48 on regulatory T cells in hepatocellular carcinoma
Wang, Z., He, L., Li, W., Xu, C., Zhang, J., Wang, D., Dou, K., Zhuang, R., Jin, B., Zhang, W., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002787 · Cited by 178
FOXP3 Defines Regulatory T Cells in Human Tumor and Autoimmune Disease
Kryczek, I., Liu, R., Wang, G., Wu, K., Shu, X., Szeliga, W., Vatan, L., Finlayson, E., Huang, E., Simeone, D., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3804 · Cited by 179
Kinnunen, T., Chamberlain, N., Morbach, H., Choi, J., Kim, S., Craft, J., Mayer, L., Cancrini, C., Passerini, L., Bacchetta, R., et al. (2013) · Blood · doi:10.1182/blood-2012-09-457465 · Cited by 177
Self-citationMorikawa, H., & Sakaguchi, S. (2014) · Immunological Reviews · doi:10.1111/imr.12174 · Cited by 176
Jürgens, B., Hainz, U., Fuchs, D., Felzmann, T., & Heitger, A. (2009) · Blood · doi:10.1182/blood-2008-12-195073 · Cited by 176
Circulating tumor antigen-specific regulatory T cells in patients with metastatic melanoma
Vence, L., Palucka, A. K., Fay, J. W., Ito, T., Liu, Y.-J., Banchereau, J., & Ueno, H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710557105 · Cited by 175
“2 A and B), which is consistent with previous reports (30, 31).”
ResultIs FOXP3 a bona fide marker for human regulatory T cells?
Roncarolo, M., & Gregori, S. (2008) · European Journal of Immunology · doi:10.1002/eji.200838168 · Cited by 174
Self-citationKatz, S. C., Bamboat, Z. M., Maker, A. V., Shia, J., Pillarisetty, V. G., Yopp, A. C., Hedvat, C. V., Gonen, M., Jarnagin, W. R., Fong, Y., et al. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-012-2668-9 · Cited by 171
“In addition, we recognize that FoxP3 is not a perfect marker for Treg in humans.(34,35) Finally, treatmentrelated variables such as liver-directed therapy following resection or systemic regimens prior to referral for treatment of CRCLM may have impacted the outcomes of certain patients.”
BackgroundRegulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis
MacDonald, K. G., Dawson, N. A. J., Huang, Q., Dunne, J. V., Levings, M. K., & Broady, R. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2014.12.1932 · Cited by 170
Self-citationBloom, D. D., Chang, Z., Fechner, J. H., Dar, W., Polster, S. P., Pascual, J., Turka, L. A., & Knechtle, S. J. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.02134.x · Cited by 170
“The generation of CD25− Teff cells to become bone fide Tregs remains controversial in human studies (50) but others have convincingly shown that human peripheral Tregs can be derived from the memory T-cell pool (51).”
BackgroundKmieciak, M., Gowda, M., Graham, L., Godder, K., Bear, H. D., Marincola, F. M., & Manjili, M. H. (2009) · Journal of Translational Medicine · doi:10.1186/1479-5876-7-89 · Cited by 167
Phenotypical characterization of regulatory T cells in humans and rodents
Rodríguez-Perea, A. L., Arcia, E. D., Rueda, C. M., & Velilla, P. A. (2016) · Clinical and Experimental Immunology · doi:10.1111/cei.12804 · Cited by 166
Manigold, T., & Racanelli, V. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70289-x · Cited by 164
CD28 Costimulation Is Essential for Human T Regulatory Expansion and Function
Golovina, T. N., Mikheeva, T., Suhoski, M. M., Aqui, N. A., Tai, V. C., Shan, X., Liu, R., Balcarcel, R. R., Fisher, N., Levine, B. L., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.4.2855 · Cited by 164
“Upon T cell activation Foxp3 is transiently induced (71–73), and this induction does not result in suppressive activity (74).”
BackgroundZhang, Y., Liu, Z., Tian, M., Hu, X., Wang, L., Ji, J., & Liao, A. (2018) · Cellular & Molecular Immunology · doi:10.1038/cmi.2017.70 · Cited by 164
The Cellular and Molecular Mechanisms of Immuno-Suppression by Human Type 1 Regulatory T Cells
Gregori, S., Goudy, K. S., & Roncarolo, M. G. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00030 · Cited by 161
“Similar to other human effector T cells (Allan et al., 2007; Passerini et al., 2008), Tr1 cells transiently express FOXP3 upon activation (Levings et al., 2005, and S. Gregori and M. G. Roncarolo, personal communication); however, FOXP3 expression in Tr1 cells is not maintained after activation and…”
BackgroundSelf-citationDutzan, N., Gamonal, J., Silva, A., Sanz, M., & Vernal, R. (2009) · Journal of Clinical Periodontology · doi:10.1111/j.1600-051x.2009.01390.x · Cited by 162
Lan, Q., Fan, H., Quesniaux, V., Ryffel, B., Liu, Z., & Guo Zheng, S. (2012) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjr039 · Cited by 160
Ebinuma, H., Nakamoto, N., Li, Y., Price, D. A., Gostick, E., Levine, B. L., Tobias, J., Kwok, W. W., & Chang, K.-M. (2008) · Journal of Virology · doi:10.1128/jvi.01548-07 · Cited by 161
“While FoxP3 can be expressed by activated human T cells (3), HCV-specific FoxP3 T cells in our study were functional Tregs based on their ability to suppress effector CD8 T-cell proliferation.”
BackgroundLineage stability and phenotypic plasticity of Foxp3+ regulatory T cells
Hori, S. (2014) · Immunological Reviews · doi:10.1111/imr.12175 · Cited by 158
Miyara, M., Chader, D., Sage, E., Sugiyama, D., Nishikawa, H., Bouvry, D., Claër, L., Hingorani, R., Balderas, R., Rohrer, J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508224112 · Cited by 157
“For example, any human conventional CD4 T cell can transiently up-regulate FOXP3 upon activation; such FOXP3 T cells are hardly suppressive (3).”
BackgroundHimmel, M. E., Hardenberg, G., Piccirillo, C. A., Steiner, T. S., & Levings, M. K. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02939.x · Cited by 155
Self-citationSuppression assays with human T regulatory cells: A technical guide
McMurchy, A. N., & Levings, M. K. (2012) · European Journal of Immunology · doi:10.1002/eji.201141651 · Cited by 147
Self-citationNatural Regulatory T Cells and Persistent Viral Infection
Li, S., Gowans, E. J., Chougnet, C., Plebanski, M., & Dittmer, U. (2008) · Journal of Virology · doi:10.1128/jvi.01768-07 · Cited by 149
“(141), produce IL-2 and gamma interferon (IFN- ), retain CD127 expression, and have no suppressor function (3, 141).”
BackgroundMjösberg, J., Svensson‐Arvelund, J., Johansson, E., Hellström, L., Casas, R., Jenmalm, M. C., Boij, R., Matthiesen, L., Jönsson, J., Berg, G. E., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803654 · Cited by 164
“The Foxp3 Ab clone PCH101 binds the amino terminus of the Foxp3 protein and has been shown to recognize both isoforms of the Foxp3 protein (7).”
Background
Metadata
- Authors
- Allan, S. E., Crome, S. Q., Crellin, N. K., Passerini, L., Steiner, T. S., Bacchetta, R., Roncarolo, M. G., & Levings, M. K.
- Affiliations
- University of British Columbia (CA)
- The San Raffaele Telethon Institute for Gene Therapy (IT)
- Vita-Salute San Raffaele University (IT)
- Venue
- International Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-02-20
- Volume
- 19
- Issue
- 4
- Pages
- 345-354
- ISSN
- 0953-8178 (ISSN-L)
- 1460-2377
- OpenAlex
- W2139019810
- Cited by
- 872
- References
- 39
- Citations by year
- 2026: 13 · 2025: 24 · 2024: 24 · 2023: 21 · 2022: 25 · 2021: 33 · 2020: 22 · 2019: 34 · 2018: 34 · 2017: 36 · 2016: 26 · 2015: 46 · 2014: 62 · 2013: 62 · 2012: 67
- FWCI
- 34.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Immunology (publishedVersion)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- Foxp3, CD4+CD25+ T cells, T cell activation, T cell proliferation, cytokine production, CD127, interleukin-2, interferon-gamma, immune tolerance, human T cells
- MeSH terms
- CD69 Antigens, Antibodies, Antigens, Differentiation, Antigens, Differentiation, T-Lymphocyte, Cell Line, Cysteine, Flagellin, Humans, Interferon-gamma, Interleukin-2, Lipoproteins, Lymphocyte Activation, CD4-Positive T-Lymphocytes, Antigens, CD, T-Lymphocyte Subsets, Cytokines, CD3 Complex, Receptors, Nerve Growth Factor, Clonal Anergy, CD28 Antigens, Receptors, Tumor Necrosis Factor, Coculture Techniques, Lectins, C-Type, Cell Proliferation, T-Lymphocytes, Regulatory, Toll-Like Receptors, Forkhead Transcription Factors, Glucocorticoid-Induced TNFR-Related Protein, Interleukin-2 Receptor alpha Subunit, Interleukin-7 Receptor alpha Subunit, CTLA-4 Antigen
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.